Max Biopharma, Inc.

Max Biopharma, Inc. is a biotech company in Santa Monica, United States, founded in 2016. It has raised $7.7M across 6 rounds, most recently a $1.8M Grant in May 2023.

Home - ::: MAX BioPharma :::

Employees
1–10
Founded
2016
Business Model
B2G
Total Funding
$7.7M
Last Round
$1.8M GrantMay 2023
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds for this company. The full record is or through the API.

About

MAX BioPharma is a privately-held, preclinical-stage California-based biopharmaceutical company pioneering the field of Oxysterol Therapeutics. The company develops novel small molecule lipid drug candidates — oxysterols — for intervention in debilitating human diseases including metabolic dysfunction-associated steatohepatitis (MASH), oncology indications (lung and pancreatic cancer), inflammatory diseases, and bone disorders. Its lead compound Oxy210 is an orally bioavailable oxysterol with antifibrotic and anti-inflammatory properties being developed for MASH. MAX BioPharma's intellectual property portfolio is supported by collaborations with UCLA, Emory School of Medicine, Case Western Reserve, and Ohio State University, with funding from CIRM, NIH SBIR/STTR programs (NIA, NHLBI, NIDDKD, NCI), and strategic partnerships including Technomark Life Sciences and Metaba.

Summary

It lists 1–10 employees. It has raised $7.7M in total across 6 rounds, most recently a $1.8M Grant round in May 2023.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)May 2023
$1.8M

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Max Biopharma, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/max-biopharma-inc"><img src="https://indexed.vc/api/badge/company/max-biopharma-inc" alt="Max Biopharma, Inc. on Indexed.vc" width="260" height="76" /></a>